Windsor Door Upgrades Little Rock, Arkansas, Operations
06/17/2024
The $21 million investment will include a new production line that will double the facility’s current output.
“Since 1964, Windsor Door’s reputation has been renowned for building garage doors that are reliable, functional and aesthetically appealing,” said Bob Strahan, President of Windsor Door. “This new production line signifies our commitment to drive innovation in our processes, products and responsiveness to customer needs.”
Windsor Door produces residential garage doors and commercial upward acting doors for homeowners, builders and architects. Products range from CFC-Free insulated garage and sectional steel commercial doors to a complete line of hardware.
“Congratulations to Windsor Door on expanding in Arkansas with a $21 million investment,” noted Clint O’Neal, executive director of the Arkansas Economic Development Commission. “Windsor Door’s new state-of-the-art production line is a testament to the company’s success, and we look forward to their continued growth in the Natural State.”
Project Announcements
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
Solstice Advanced Materials Expands Chesterfield County, Virginia, Manufacturing Operations
01/16/2026
TransMedics Group Plans Somerville, Massachusetts, Headquarters Operations
01/16/2026
AVAIO Digital Partners Plans Pulaski County, Arkansas, Data Center Operations
01/14/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025